News
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
13h
Barchart on MSNHuge Unusual Volume in Pfizer Put Options Signals Investors Bullish OutlookLarge unusual trading volume in Pfizer, Inc. (PFE) put options that expire 30 days from now signals investors' bullish ...
We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
Dr. Philip Dormitzer, former global head of vaccine research and development at Pfizer, has been subpoenaed by the House Judiciary Committee as it investigates Pfizer’s alleged delay in the release of ...
During a Senate Judiciary Committee hearing last week, Sen. Richard Blumenthal (D-CT) questioned Kansas Attorney General Kris ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Shares of Pfizer Inc. PFE rose 1.12% to $25.32 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.47% to 6,227.42 and the Dow ...
Pfizer Share Price – Track LIVE BSE/NSE stock prices of Pfizer with insights on performance, fundamentals, market cap, shareholding, financials, company profile, balance sheet, annual and quarterly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results